| BUSINESS STRATEGY |
BETTER ACCESS to medicinal chemistry expertise was the reason that Co a U.S. drug development services company, established a partnership in small-molecule drug discovery with the Indian Partner Co. Partner which opened for business only a year ago, is building a new facility in Hyderabad, India, to conduct medicinal chemistry and biology R&D for Co.`s clients and Co.`s own drug discovery program. Co explained that "the lack of adequate medicinal chemistry resources is a major bottleneck in rapidly optimizing a drug lead."
Although Co emphasized access to resources, other U.S. companies active in India acknowledge frankly that an attraction of doing chemistry there is the cost
|